Our results suggest that NLRP3 inflammasome may drive the development of AD in the HSV-1 infection condition, and inhibition of NLRP3 signaling have potential to prevent Aβ accumulation and cognitive decline of AD. The gene discussed is NLRP3; the disease is Alzheimer disease.